DeepMind turns AI toward biosecurity
Google DeepMind and Isomorphic Labs laid out a bioresilience program that uses frontier AI to prevent misuse, detect outbreaks and speed medical countermeasures.
AI drug discovery News and Analysis
6 verified stories covering AI drug discovery, product updates and industry developments.
OpenAI tests biology judgment, and GPT-5.6 clears only 31.5%
GeneBench-Pro uses messy biological datasets to test whether models can make research decisions, not just answer textbook questions.
Anthropic Moves From Claude Science Into Drug Discovery
Anthropic launched Claude Science and said it will pursue drug discovery programs for neglected diseases that large pharma often ignores.
GPT-5.4 lifts Chan-Lam yields in wet-lab tests
OpenAI and Molecule.one used GPT-5.4 to identify TEMPO as an additive, raising average Chan-Lam coupling yields from 16.6% to 25.2% across high-throughput experiments.
OpenAI updates GPT-Rosalind for life sciences
OpenAI’s life-science model adds agentic coding, research plugins and NGS analysis tools, while cutting token use by 31% on long quantitative biology tasks.
Waypoint Bio raises $20M for AI-validated cell therapies
Waypoint Bio is using spatial biology and AI to validate in vivo CAR-T candidates for solid tumors before costly clinical trials.